Vertex Pharmaceuticals | VRTX - Pe Kurs-Gewinn

Aktienkurs
462.49
Täglich Wechseln
-3.61 -0.77%
Monatlich
-1.66%
Jährlich
-9.71%
Q1 Prognose
455.17




Pe Veränderung Datum
AbbVie 24.03 86.23 2025-12
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 23.62 0.86 2025-12
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 15.74 0.15 2025-09
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sanofi 11.99 1.58 2025-12
Sarepta Therapeutics 27.27 0 2025-09
United Therapeutics 17.32 1.62 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12